Press Releases December 5, 2024: MaaT Pharma Announces First U.S. Patient Treated at City of Hope Under Single Patient Expanded Access for MaaT013 in Acute Graft-versus-Host Disease MaaT Pharma Announces First U.S. Patient Treated at City of Hope Under Single Patient Expanded…MaaT PharmaDecember 5, 2024
